va glp 1 Veterans GLP-1 Weight Management Study Insights VA Study: Ozempic, Other GLP-1

Some compounding operations may face restrictions, which could affect supply chains and potentially lead to pharmacy switches for patients on ongoing treatment programs

Additional industry projections suggest GLP-1 therapies are on track to become one of the most commercially successful drug categories ever, with annual sales projections of $150 billion or more by the end of the decade

However, their clinical utility remains limited due to heterogeneous metabolic effects and adverse outcomes, such as elevated alanine aminotransferase (ALT), increased low-density lipoprotein cholesterol (LDL-C), and weight gain (55)

Concerns about a potential link to pancreatitis were raised in early observations

This complementary action addresses multiple pathophysiologic defects of T2D 32

Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk